1 / 1

RLU (fold)

-. -. -. -. -. -. -. -. +. +. +. +. +. +. +. +. AR. AR. -. -. -. -. -. -. -. -. -. -. -. -. +. +. +. +. SRC-1. SRC-1. -. -. -. -. -. -. -. -. -. -. +. +. -. -. SRC-2. SRC-2. +. +. -. -. -. -. -. -. -. -. -. -. -. -. +. +. +. +.

ashton
Télécharger la présentation

RLU (fold)

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. - - - - - - - - + + + + + + + + AR AR - - - - - - - - - - - - + + + + SRC-1 SRC-1 - - - - - - - - - - + + - - SRC-2 SRC-2 + + - - - - - - - - - - - - + + + + SRC-3 SRC-3 B A L-O2 Huh-7 18 100 ctrl ctrl 16 90 R1881 R1881 80 14 70 12 RLU (fold) 60 RLU (fold) 10 50 8 40 6 30 4 20 2 10 0 0 Supplementary Fig. 8. SRC-3 exhibits the highest co-activating activity to AR. SRC-1/2/3 and AR together with AR reporter were co-transfected into human L-O2 cells (A) and Huh-7 cells (B) respectively in the absence or presence of AR agonist R1881. Supplementary Figure 8

More Related